AddLife AB (publ) (0REZ.L) LSE

184.50

+4.19829(+2.33%)

Updated at October 21 11:01AM

Currency In SEK

AddLife AB (publ)

Address

Brunkebergstorg 5

Stockholm, 103 62

Sweden

Phone

46 8 42 00 38 30

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

2251

First IPO Date

April 11, 2016

Key Executives

NameTitlePayYear Born
Mr. Fredrik DalborgPresident & Chief Executive Officer10.34M1972
Julie O'LearyInvestor Relations Manager0N/A
Timmy RosendalHead of Sustainability0N/A
Johanna PrimGroup Financial Controller0N/A
Nichlas EssnerGroup Business Controller0N/A
Malin LindhGroup Business Controller0N/A
Ms. Christina RubenhagChief Financial Officer01970
Ms. Jamilah WassGroup Financial Controller0N/A

Description

AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.